Compare · LFMD vs LFST
LFMD vs LFST
Side-by-side comparison of LifeMD Inc. (LFMD) and LifeStance Health Group Inc. (LFST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFMD and LFST operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $4.49B, about 22.4x LFMD ($200.7M).
- Over the past year, LFMD is down 59.8% and LFST is up 175.1% - LFST leads by 234.8 points.
- LFST has hit the wire 13 times in the past 4 weeks while LFMD has been quiet.
- LFST has more recent analyst coverage (17 ratings vs 11 for LFMD).
- Company
- LifeMD Inc.
- LifeStance Health Group Inc.
- Price
- $4.19+1.21%
- $11.47-0.86%
- Market cap
- $200.7M
- $4.49B
- 1M return
- -14.84%
- +33.37%
- 1Y return
- -59.75%
- +175.06%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 0
- 13
- Recent ratings
- 11
- 17
LifeMD Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Latest LFMD
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
- LifeMD Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
- Chief Technology Officer Sripad Umesh was granted 75,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Sripad Umesh
- LifeMD Appoints Umesh Sripad as Chief Technology Officer
- LifeMD to Participate in Upcoming Investor Conferences
- Chief Financial Officer Kavthekar Atul was granted 337,500 shares (SEC Form 4)
- SEC Form 10-Q filed by LifeMD Inc.
- LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Latest LFST
- LifeStance to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026
- Director Burdick Kenneth A was granted 45,495 shares, increasing direct ownership by 1% to 3,470,810 units (SEC Form 4)
- Director Palmer Eric P was granted 17,746 shares, increasing direct ownership by 25% to 89,174 units (SEC Form 4)
- Director Bessler Robert was granted 17,746 shares, increasing direct ownership by 31% to 75,365 units (SEC Form 4)
- Director Personette Sarah was granted 17,746 shares, increasing direct ownership by 24% to 92,512 units (SEC Form 4)
- Director Deluca Teresa was granted 17,746 shares, increasing direct ownership by 17% to 125,034 units (SEC Form 4)
- Director Justice Thurman was granted 35,492 shares (SEC Form 4)
- Director Goltermann Lori was granted 35,492 shares (SEC Form 4)
- SEC Form 3 filed by new insider Goltermann Lori
- SEC Form 3 filed by new insider Justice Thurman